| Literature DB >> 29407252 |
Armin Rashidi1, Maryam Ebadi2, Robin R Shields-Cutler3, Todd E DeFor4, Gabriel A Al-Ghalith3, Patricia Ferrieri5, Jo-Anne H Young6, Gary M Dunny7, Dan Knights3, Daniel J Weisdorf8.
Abstract
Pretransplant gut colonization with intrinsically vancomycin-resistant enterococci (iVRE) (Enterococcus gallinarum and Enterococcus casseliflavus) is uncommon and with unknown clinical impact. In a matched-pairs analysis of patients with versus without iVRE colonization (n = 18 in each group), we demonstrated significantly higher 2-year overall survival (86% [95% confidence interval, 52% to 96%] versus 35% [95% confidence interval, 8% to 65]; P <.01) and lower nonrelapse mortality (P <.01) among colonized patients. Putative metabolomes differentiated iVRE from E. faecalis/faecium and may contribute to a healthier gut microbiome in iVRE-colonized patients.Entities:
Keywords: Allogeneic; Biosynthetic; Colonization; Enterococcus; Vancomycin
Mesh:
Year: 2018 PMID: 29407252 PMCID: PMC6824584 DOI: 10.1016/j.bbmt.2018.01.025
Source DB: PubMed Journal: Biol Blood Marrow Transplant ISSN: 1083-8791 Impact factor: 5.742